Fuso Pharmaceutical Licenses Cancer Vaccine Rights To Otsuka
This article was originally published in PharmAsia News
Executive Summary
Fuso Pharmaceutical Industrials Jan. 26 signed a licensing agreement and granted rights to cancer vaccine OTS102 to Tokyo-based Otsuka Pharmaceutical